Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - SELLAS Life Sciences Group, Inc. | Financial_Report.xls |
| 10-K - 10-K - SELLAS Life Sciences Group, Inc. | gale-20141231x10k.htm |
| EX-23.1 - EXHIBIT 23.1 - SELLAS Life Sciences Group, Inc. | gale-20141231xex231.htm |
| EX-31.2 - EXHIBIT 31.2 - SELLAS Life Sciences Group, Inc. | gale-20141231xex312.htm |
| EX-32.1 - EXHIBIT 32.1 - SELLAS Life Sciences Group, Inc. | gale-20141231xex321.htm |
| EX-31.1 - EXHIBIT 31.1 - SELLAS Life Sciences Group, Inc. | gale-20141231xex311.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Galena Biopharma, Inc.
Portland, Oregon
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-167025, 333-174076, 333-188847, 333-182505, 333-181589 and 333-188849), Form S-3MEF (No. 333-185526), and Form S-8 (No. 333-151154, 333-153847, 333-175763, 333-174819, 333-183300, 333-182578, and 333-190540) of Galena Biopharma, Inc. of our report dated March 12, 2013, relating to the consolidated financial statements, which appear in this Form 10-K.
/s/ BDO USA, LLP
Seattle, Washington
March 5, 2015